News
Events
Blog
Contact
Ask the Experts
Board of Directors
Volunteers
Careers
What we do
Integrated Programs
Turnkey solutions for shortening development times
Candidate Selection
Selecting the right molecules for development
Early Development
Accelerating molecules through to proof-of-concept
Late Development
Accelerating products through to commercial manufacture
Tailored Services
Individual services to meet customer needs
Formulation Development
Dosage Forms, Pre-Formulation, Solubilization, Modified Release, Pediatrics
Clinical Trial Manufacturing
Phase I-III Clinical Supplies, Adaptive Manufacturing, High Potency API’s
Commercial Manufacturing
Tech Transfer, Scale-Up, Registration, Process Validation
Clinical Pharmacology
First-in-Human, BA/BE, Human ADME, Pharmacy Compounding
Drug Development Consulting
Scientific Advice, Developability Assessment, Program Design
Data Sciences
Data Management, Programming, Statistics/PK, Medical Writing
Drug Substance
Route Scouting, PR&D, Small-Scale GMP Manufacture, DOE/QbD
Bioanalysis
Biotransformation, Quantitative Biological & Chemical Analysis
About Quotient Sciences
At a Glance
We accelerate drug development. Saving precious time in getting medicines to patients.
Translational Pharmaceutics®
Our flagship platform for accelerating drug development.
Our Manifesto
We believe molecules need to become cures, fast. Because humanity needs solutions, fast.
Life at Quotient
Explore how team work is the key to our success
Science, Agility, Culture
Finding creative solutions, delivering for our customers.
Awards & Achievements
We have been recognized with various awards throughout the years. Take a look now.
Resources
Whitepaper
Accelerating the Development of Oncology Medicines
Oncology drugs dominate today’s research focus with over >5500 molecules in development, representing over 35% …
Whitepaper
Accelerating the Developing of Orphan Drugs for Rare Diseases
Worldwide there are over 300 million people living with identified rare diseases. This white paper …
Case Studies
Druggability Technologies
Druggability Technologies (DRGT) is developing DRGT-46 as a novel therapy for pain. Gabor Heltovics, CEO …
Resources
Case studies
Info sheets
Scientific posters
Whitepapers
Webinars
What we do
Back
What we do
Integrated Programs
Back
What we do
Candidate Selection
Early Development
Late Development
Tailored Services
Back
What we do
Formulation Development
Clinical Trial Manufacturing
Commercial Manufacturing
Clinical Pharmacology
Drug Development Consulting
Data Sciences
Drug Substance
Bioanalysis
About Quotient Sciences
Back
About Quotient Sciences
At a Glance
Translational Pharmaceutics®
Our Manifesto
Life at Quotient
Science, Agility, Culture
Awards & Achievements
Resources
Back
Resources
Case studies
Info sheets
Scientific posters
Whitepapers
Webinars
Quick links
Back
News
Events
Blog
Contact
Ask the Experts
Board of Directors
Volunteers
Careers
Press enter to search
Suggested searches
Early Development
Candidate Selection
Late Development
Tailored Services
Translational Pharmaceutics
Events
Events
View past events
Categories
Exhibition
Seminar
Event
Month
August 2021
May 2021
July 2021
June 2021
Reset filters
Filter
8
/ 8 events
May 11
Seminar
Accelerating Development of 505(b)(2) Products- Webinar Series
Register today for our 505(b)(2) webinar series taking place on May 11th, 13th and 18th, entitled- Accelerating Development of 505(b)(2) drug products: A competitive and alternative strategy
May 11
Seminar
Accelerating Development of 505(b)(2) Drug Products: A Competitive and Alternative Strategy- May 11
Join us on Tuesday, May 11th for a Live Webinar- Accelerating Development of 505(b)(2) Drug Products: A Competitive and Alternative Strategy
May 13
Seminar
Accelerating Development of 505(b)(2) Drug Products: A Competitive and Alternative Strategy- May 13
Join us on May 13th for a Live Webinar- Accelerating Development of 505(b)(2) Drug Products: A Competitive and Alternative Strategy
May 18
Seminar
Accelerating Development of 505(b)(2) Drug Products: A Competitive and Alternative Strategy- May 18th
Join us on Tuesday, May 18th for a live webinar- Accelerating Development of 505(b)(2) Drug Products: A Competitive and Alternative Strategy
May 20
Event
Bio Integrates 2021
Nathalie Huther of Arcinova - A Quotient Sciences Business, will be joining the panel discussion “It ain’t what you do, it’s the way that you do it” on May 20, 2021
Jun 10
Exhibition
BIO Digital 2021
Schedule a partnering meeting with our drug development experts at the BIO digital event today!
Jul 25
Event
Controlled Release Society 2021 Virtual Annual Meeting
Quotient will be presenting a poster entitled: "Using formulation design spaces and clinical data to optimize development of modified release (MR) dosage forms".
Aug 10
Exhibition
CPhI North America 2021
We will be attending CPhI North America in Philadelphia on August 10th-12th. Schedule a meeting today!
Drug Substance
Formulation Development
Bioanalysis
Clinical Trial Manufacturing
Commercial Manufacturing
Clinical Pharmacology
Data Sciences
Drug Development Consulting
Ask us a question
We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.
Decline
Accept
